Smartleaf Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Smartleaf Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$933	Hold	48	–	–	﹤0.01%	3105
2026 Q1	$416	Hold	48	–	–	﹤0.01%	3253
2025 Q4	$651	Hold	48	–	–	﹤0.01%	3228
2025 Q3	$1.03K	Buy	+48	New	+$565	﹤0.01%	2740
2025 Q2	–	Sell	-48	Closed	-$574	–	2773
2025 Q1	$574	Buy	+48	New	+$746	﹤0.01%	2681

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Smartleaf Asset Management's CLPT Position: Q2 2026 in Review

Smartleaf Asset Management held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 48 shares worth $933. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

Smartleaf Asset Management first reported a position in CLPT in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.03K in Q3 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Smartleaf Asset Management held 48 shares of ClearPoint Neuro worth $933 as of Q2 2026.
Smartleaf Asset Management left its ClearPoint Neuro share count unchanged in Q2 2026.
ClearPoint Neuro made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3105 holding.
Smartleaf Asset Management first reported a position in ClearPoint Neuro in Q1 2025 and has held it in 5 quarters since.
Smartleaf Asset Management's ClearPoint Neuro position peaked at $1.03K in Q3 2025.
128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.